MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/cns.70649

Медицинская библиотека · CNS neuroscience & therapeutics · 2025

Fingolimod Exerts Therapeutic Effects on Autistic Mice via Improving the Structure and Function of Meningeal Lymphatics.

Hong Chen, Xiao Han-Lian, Sun Zhi-Hui, Guo Ruo-Bing, Zhang Xi-Yue, Ji Juan, Sun Xiu-Lan

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Accumulating evidence suggests a correlation between maternal infection during pregnancy and an increased risk of autism spectrum disorder (ASD) in offspring. Our previous studies have demonstrated that maternal immune activation (MIA) induces autism-like behaviors in offspring mice, accompanied by significant lateral ventricular enlargement and cerebrospinal fluid (CSF) circulation deficits. As a critical pathway for CSF drainage, the role of meningeal lymphatic vessels in the pathophysiology of ASD remains uncharacterized. Fingolimod (FTY720), a clinically used immunomodulator, has been shown to ameliorate autism-like behaviors, but its underlying mechanism remains unclear.

METHODS

We utilized an MIA-induced autism-like offspring mouse model. Autism-like behaviors in the mice were assessed using three-chamber social interaction, marble burying, grooming and other related behavioral tests. The size of the lateral ventricles was evaluated by magnetic resonance imaging and hematoxylin and eosin staining. The structure and function of meningeal lymphatic vessels were examined using immunofluorescence and in vivo visible light imaging. Lymphangiogenesis was investigated through techniques such as Western blotting, tube formation assays, sprouting experiments and other relevant methods.

RESULTS

FTY720 not only alleviates autism-like behaviors and lateral ventricular dilation, but also significantly restores the structural integrity and drainage function of meningeal lymphatic vessels in MIA offspring. Furthermore, in vitro experiments reveal that FTY720 promotes lymphangiogenesis by targeting the S1PR3 receptor to inhibit the expression of thrombospondin-1 (TSP1), a lymphangiogenesis-related inhibitor.

CONCLUSION

FTY720 acts on the S1PR3 receptor to inhibit TSP1, thereby improving the structure and function of meningeal lymphatic vessels and alleviating autism-like behaviors and lateral ventricular dilation.

Для цитирования: Hong Chen, Xiao Han-Lian, Sun Zhi-Hui, Guo Ruo-Bing, Zhang Xi-Yue, Ji Juan, Sun Xiu-Lan. Fingolimod Exerts Therapeutic Effects on Autistic Mice via Improving the Structure and Function of Meningeal Lymphatics.. CNS neuroscience & therapeutics. 2025. DOI: 10.1111/cns.70649.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.